17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes

Cardiovascular Research

Volumn 96, Issue 3, 2012, Pages 411-421

  Mahmoodzadeh, Shokoufeh ^a   Pham, Thi Hang ^a   Kuehne, Arne ^a   Fielitz, Britta ^a   Dworatzek, Elke ^a   Kararigas, Georgios ^a   Petrov, George ^b   Davidson, Mercy M ^c   Regitz Zagrosek, Vera ^a,b  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Atrial natriuretic peptide precursor A; Cardiomyocyte; Gene expression; Oestrogen; Oestrogen receptor

Indexed keywords

ALPHA ACTININ 2; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COMPLEMENTARY DNA; CONNEXIN 43; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; NATRIURETIC PEPTIDE RECEPTOR A; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; HEART ATRIUM; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; TRANSCRIPTION TERMINATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, C-TYPE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84869388387     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs281     Document Type: Article

References (40)

1. Modena MG, Molinari R, Muia N Jr, Castelli A, Pala F, Rossi R. Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women. Am J Hypertens 1999;12:1000-1008. (Pubitemid 29528699)
2. Patten RD, Karas RH. Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med 2006;16:69-75.
3. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006;5:425-438.
4. Kararigas G, Bito V, Tinel H, Becher E, Baczko I, Knosalla C et al. Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J Am Coll Cardiol 2012;59:410-417.
5. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-1587. (Pubitemid 40807497)
6. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002;90:3F-6F. (Pubitemid 34775144)
7. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas RH, Vetter H et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 1997;416:107-112. (Pubitemid 27470812)
8. Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J et al. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 2004;110:3270-3275. (Pubitemid 39525076)
9. Babiker FA, De Windt LJ, van Eickels M, Thijssen V, Bronsaer RJ, Grohe C et al. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation 2004;109:269-276. (Pubitemid 38114150)
10. Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham TH, Regitz-Zagrosek V. 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res 2010;85:719-728.
11. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007;87:905-931. (Pubitemid 47084672)
12. Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997;387:733-736. (Pubitemid 27270617)
13. Xu L, Glass CK, Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999;9:140-147. (Pubitemid 29158546)
14. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-328. (Pubitemid 28366422)
15. Davidson MM, Nesti C, Palenzuela L, Walker WF, Hernandez E, Protas L et al. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 2005;39:133-147. (Pubitemid 40836050)
16. Mahmoodzadeh S, Fritschka S, Dworatzek E, Pham TH, Becher E, Kuehne A et al. Nuclear factor-kappaB regulates estrogen receptor-alpha transcription in the human heart. J Biol Chem 2009;284:24705-24714.
17. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000;127:4277-4291.
18. Mahmoodzadeh S, Eder S, Nordmeyer J, Ehler E, Huber O, Martus P et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. Faseb J 2006; 20:926-934. (Pubitemid 44943950)
19. Pedram A, Razandi M, Aitkenhead M, Levin ER. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 2005;280:26339-26348. (Pubitemid 41022232)
20. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001;29:2905-2919. (Pubitemid 32685217)
21. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 2001;104:1419-1423. (Pubitemid 32880156)
22. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94. (Pubitemid 11184926)
23. Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 1996;137:817-824. (Pubitemid 26070361)
24. Poulos JE, Gower WR Jr, Sullebarger JT, Fontanet HL, Vesely DL. Congestive heart failure: increased cardiac and extracardiac atrial natriuretic peptide gene expression. Cardiovasc Res 1996;32:909-919. (Pubitemid 26342656)
25. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 1989;83:298-305. (Pubitemid 19048436)
26. Bloch KD, Scott JA, Zisfein JB, Fallon JT, Margolies MN, Seidman CE et al. Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science 1985; 230:1168-1171. (Pubitemid 16170005)
27. Shields PP, Glembotski CC. The post-translational processing of rat pro-atrial natri-uretic factor by primary atrial myocyte cultures. J Biol Chem 1988;263:8091-8098.
28. Horsthuis T, Houweling AC, Habets PE, de Lange FJ, el Azzouzi H, Clout DE et al. Distinct regulation of developmental and heart disease-induced atrial natriuretic factor expression by two separate distal sequences. Circ Res 2008;102:849-859. (Pubitemid 351521591)
29. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008;21:733-741. (Pubitemid 351913612)
30. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000;35:19-24. (Pubitemid 30054231)
31. Albrecht U, Bordon A, Schmutz I, Ripperger J. The multiple facets of Per2. Cold Spring Harb Symp Quant Biol 2007;72:95-104.
32. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000; 275:39855-39859. (Pubitemid 32065755)
33. Calderone A, Bel-Hadj S, Drapeau J, El-Helou V, Gosselin H, Clement R et al. Scar myofibroblasts of the infarcted rat heart express natriuretic peptides. J Cell Physiol 2006;207:165-173.
34. Shan X, Wang H, Margulies KB. Apoptosis signal-regulating kinase 1 attenuates atrial natriuretic peptide secretion. Biochemistry 2008;47:10041-10048.
35. Gonzalez M, Reyes R, Damas C, Alonso R, Bello AR. Oestrogen receptor alpha and beta in female rat pituitary cells: an immunochemical study. Gen Comp Endocrinol 2008; 155:857-868.
36. Hart SA, Snyder MA, Smejkalova T, Woolley CS. Estrogen mobilizes a subset of estrogen receptor-alpha-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1. J Neurosci 2007;27:2102-2111.
37. Micevych P, Bondar G, Kuo J. Estrogen actions on neuroendocrine glia. Neuroendocri-nology 2010;91:211-222.
38. Scott NJ, Ellmers LJ, Lainchbury JG, Maeda N, Smithies O, Richards AM et al. Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim Biophys Acta 2009;1792:1175-1184.
39. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, Krabatsch T, Dunkel A, Dandel M et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 2010;122:S23-S28.
40. Qin X, Wang XH, Yang ZH, Ding LH, Xu XJ, Cheng L et al. Repression of NFAT3 transcriptional activity by estrogen receptors. Cell Mol Life Sci 2008;65:2752-2762.